Studying endothelial damage in COVID-19
Menarini Silicon Biosystems, a leader in the field of rare cells isolation and analysis, has put in place its resources to contribute advancing the knowledge on COVID-19.
COVID-19 is often associated with cardiovascular complications and endothelial damage. Studies have shown that the number of endothelial cells that are circulating in the bloodstream (CECs) can be a specific and sensitive marker of endothelial damage and could help identify the most severe COVID-19 cases.
Menarini Silicon Biosystem’s CELLSEARCH® platform, in combination with the CELLSEARCH® Circulating Endothelial Cell Kit*, is able to capture and enumerate CECs in peripheral blood and ongoing studies are aimed at demonstrating that enumeration of CECs is a potential biomarker of cardiovascular complications.
* For Research Use Only. Not for use in diagnostic procedures. The performance characteristics, safety, and effectiveness have not been established and are not cleared or approved by the FDA.
Read More